書籍情報から探す
日本人2型糖尿病患者を対象としたイプラグリフロジンの安全性と有効性の検討 - 長期使用に関する特定使用成績調査STELLA-LONG TERMの中間報告 (24ヵ月) -
日本人2型糖尿病患者に対するイプラグリフロジンの肥満度別での安全性と有効性の検討 - 長期特定使用成績調査STELLA-LONG TERMの中間報告 (24ヵ月) -
Questionnaire Survey on the Current Status of Pharmacist Practice and Patient Needs Related to Home Medical Care
Atsushi Kobayashi1), Marina Yamada2), Shimon Maegawa2), Hideki Hayashi1,2,3), Junko Kai1), Tadashi Sugiyama1,2,3)
1)Laboratory of Home Team Care Pharmacy, Gifu Pharmaceutical University, 2)Laboratory of Pharmacy Practice and Social Science, Gifu Pharmaceutical University, 3)Laboratory of Community Healthcare Pharmacy, Gifu Pharmaceutical University
薬理と治療 47 (11) 1807-1816, 2019.
1)Laboratory of Home Team Care Pharmacy, Gifu Pharmaceutical University, 2)Laboratory of Pharmacy Practice and Social Science, Gifu Pharmaceutical University, 3)Laboratory of Community Healthcare Pharmacy, Gifu Pharmaceutical University
薬理と治療 47 (11) 1807-1816, 2019.
- アブストラクト: 従量制は110円(税込)、基本料金制は基本料金に含まれます。
- 全文ダウンロード: 従量制、基本料金制の方共に1,023円(税込) です。
Effects of Tablets Containing Bacillus subtilis C-3102 Spores on Intestinal Microbiota in Healthy Volunteers with Constipation - A Randomized Placebo-controlled, Double-blind Study -
Misaki Hatanaka1), Megumi Kato2), Yasunori Nakamura2), Yousuke Honda3), Muneaki Iizuka3), Yoshitaka Iwama4)
1)Resarch Planning Group, ASAHI CALPIS WELLNESS, CO.,LTD., 2)Core Technology Laboratories, ASAHI QUALITY AND INNOVATIONS, CO.,LTD., 3)TTC Co.,Ltd., 4)Nihonbashi Cardiology Clinic
薬理と治療 47 (11) 1823-1831, 2019.
1)Resarch Planning Group, ASAHI CALPIS WELLNESS, CO.,LTD., 2)Core Technology Laboratories, ASAHI QUALITY AND INNOVATIONS, CO.,LTD., 3)TTC Co.,Ltd., 4)Nihonbashi Cardiology Clinic
薬理と治療 47 (11) 1823-1831, 2019.
- アブストラクト: 従量制は110円(税込)、基本料金制は基本料金に含まれます。
- 全文ダウンロード: 従量制、基本料金制の方共に1,023円(税込) です。
Phycocyanin Reduces Transepidermal Water Loss and Improves Skin Barrier Function in Healthy Subjects - A Randomized, Double-blind, Placebo-controlled, Parallel-group Comparison Trial -
Effect of Continuous Ingestion of Kaempferia parviflora Extract (SIRTMAX(R))-containing Diet on Glycemic Control and Safety Evaluation of Excessive Intake - A Randomized, Double-blind, Placebo-controlled Parallel-group Comparison Study -
Tomoko Kuniyoshi1), Yukiko Kobayashi1), Norimoto Shimada1), Jinwei Yang1), Shin-ichiro Yamashita2), Naoko Suzuki2), Tsuyoshi Takara3)
1)Tokiwa Phytochemical Co.,Ltd., 2)ORTHOMEDICO Inc., 3)Medical Corporation Seishinkai, Takara Clinic
薬理と治療 47 (11) 1841-1850, 2019.
1)Tokiwa Phytochemical Co.,Ltd., 2)ORTHOMEDICO Inc., 3)Medical Corporation Seishinkai, Takara Clinic
薬理と治療 47 (11) 1841-1850, 2019.
- アブストラクト: 従量制は110円(税込)、基本料金制は基本料金に含まれます。
- 全文ダウンロード: 従量制、基本料金制の方共に1,023円(税込) です。
ユーグレナ・グラシリスEOD-1株由来パラミロン含有食品摂取による日常生活における疲労感軽減効果 - ランダム化二重盲検プラセボ対照並行群間比較試験 -
Effect of a Dietary Supplement Containing Gymnema sylvestre Extract, Mulberry Leaf Extract, Green Tea Extract, Chitosan, Kidney Bean Extract, and Kaempferia parviflora Extract on Abdominal Fat of Vietnamese Adult Women - A Randomized, Double-blind, Placebo-controlled, Parallel Group Comparison Study -
Yoshiki Shimizu1), Linh Anh Vu1), Yuuri Takeshita1), Sayuri Matsuoka1), Kei Yui1), Nhung Thi Bui2), Tuyen Danh Le2), Giang Thi Huong Le3), Anh Do Van Nguyen2), Thuc Thi Minh Vu4)
1)FANCL Research Institute, FANCL Corporation, 2)National Institute of Nutrition, 3)198 Hospital, 4)National ENT Hospital
薬理と治療 47 (11) 1871-1882, 2019.
1)FANCL Research Institute, FANCL Corporation, 2)National Institute of Nutrition, 3)198 Hospital, 4)National ENT Hospital
薬理と治療 47 (11) 1871-1882, 2019.
- アブストラクト: 従量制は110円(税込)、基本料金制は基本料金に含まれます。
- 全文ダウンロード: 従量制、基本料金制の方共に1,023円(税込) です。
Efficacy and Safety of Intake of Bifidobacterium breve N708-containing Food on Diarrhea Due to Stress - Randomized Double-blind, Placebo-controlled, Parallel-group Comparison Study -
Heat-killed Lactobacillus pentosus B240 Improves Overall Face Scale Score Following Japanese Cedar Pollen Exposure in an Environmental Exposure Unit - A Randomized, Double-blind, Placebo-controlled Clinical Trial -
Takao Saito1), Koji Hamuro1), Hiroshi Saito1), Takema Sakoda2), Chika Natsume1), Keisuke Hamamoto3), Kensuke Sugaya3), Noriyuki Kohda1), Tadao Enomoto4)
1)Otsu Nutraceuticals Research Institute, Otsuka Pharmaceutical Co.,Ltd., 2)Department of Otorhinolaryngology, Rinku General Medical Center, 3)New Business and Product Development Department, Otsuka Pharmaceutical Co.,Ltd., 4)NPO Japan Health Promotion Supporting Network
薬理と治療 47 (11) 1901-1912, 2019.
1)Otsu Nutraceuticals Research Institute, Otsuka Pharmaceutical Co.,Ltd., 2)Department of Otorhinolaryngology, Rinku General Medical Center, 3)New Business and Product Development Department, Otsuka Pharmaceutical Co.,Ltd., 4)NPO Japan Health Promotion Supporting Network
薬理と治療 47 (11) 1901-1912, 2019.
- アブストラクト: 従量制は110円(税込)、基本料金制は基本料金に含まれます。
- 全文ダウンロード: 従量制、基本料金制の方共に1,023円(税込) です。
Safety Evaluation of Excessive Intake of Chicken Leg Extract (HAS-II(R)) in Healthy Adult Subjects - A Randomized, Placebo-controlled, Double-blind Study -